Paolo Mallaroni
Clinical Researcher in Psychedelic Neuroscience
Data updated
Research Footprint
Paolo Mallaroni appears in 15 tracked papers (2022–2026), most studied alongside Psilocybin, Ayahuasca and 2C-X, across Neuroimaging & Brain Measures, Healthy Volunteers and Depressive Disorders.
Most-cited paper: Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study (77 citations).
Frequent co-authors: Johannes Ramaekers, Nathalie Mason and Jan Reckweg.
Publication Landscape
How the 15 papers Blossom tracks for Paolo Mallaroni line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Paolo Mallaroni's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 15 of 15 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Paolo Mallaroni publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Paolo Mallaroni publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Paolo Mallaroni is a clinical researcher based at Maastricht University whose work sits at the intersection of experimental psychopharmacology, neuroimaging and cognitive neuroscience of psychedelics. He has contributed to placebo‑controlled experimental studies and multimodal imaging analyses examining acute and persisting effects of classic and novel psychoactive compounds, and has collaborated extensively with groups led by N.L. Mason and colleagues on projects spanning psilocybin, ayahuasca and 2C‑B. His research portfolio includes investigations of subjective phenomenology (including oceanic boundlessness), dynamic functional connectivity changes after psilocybin, structural cortical signatures of repeated ayahuasca use, cognitive effects on episodic familiarity, and immunological alterations following psilocybin administration.
Key Impact
Emerging clinical researcher notable for experimental studies on psilocybin, ayahuasca and 2C‑B that probe neural, immunological and cognitive effects of psychedelics in healthy volunteers.
Collaboration Network
32 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Paolo Mallaroni's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Paolo Mallaroni is associated with.